Status:
NOT_YET_RECRUITING
Effectiveness of an Interprofessional Approach to the Treatment of Spasticity With Botulinum Toxin & Non-pharmacological Therapies
Lead Sponsor:
Technical University of Bern
Conditions:
Spasticity
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Many people with neurological conditions will experience spasticity, a nonvolitional and uncontrollable tightening and/or spasm of muscles. This can impact the person's functioning and independence in...
Detailed Description
Cross-national, multicenter (CH and UK) single case experimental design (SCED), specifically N-of-1 series with an ABC Design (Baseline, Intervention, Follow-up). Patients with focal or multifocal spa...
Eligibility Criteria
Inclusion
- Age 18 or over
- male, female or other
- acute or chronic spasticity
- patients who have been assessed by the spasticity MDT and whose treatment plan includes Botulinum toxin and non-pharmacological therapies for focal or multi-focal spasticity and who have signed the general consent at entry.
Exclusion
- \<18 years
- Patients with spasticity, who will not receive BoNT
- Planned re-injection of BoNT before the end of the Phase C Follow-Up
- Previous BoNT injection within 3 months of baseline measurements
Key Trial Info
Start Date :
October 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2027
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT07160699
Start Date
October 1 2025
End Date
April 1 2027
Last Update
September 8 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
REHAB Basel
Basel, Switzerland, 4055
2
Royal Hospital for Neuro-disability
London, West Hill Putney, United Kingdom, SW15 3 SW